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a  b  s  t  r  a  c  t
Angiotensin  I-converting  enzyme  (ACE)  is a well-known  metallopeptidase  that  is  found  in  vertebrates,
invertebrates  and bacteria.  We  isolated  from  the anterior  gill  of the crab Ucides  cordatus  an  isoform  of  ACE,
here named  crab-ACE,  which  presented  catalytic  properties  closely  resembling  to those  of mammalian
ACE.  The  enzyme  was  puriﬁed  on  Sepharose-lisinopril  afﬁnity  chromatography  to apparent  homogene-
ity  and  a band  of  about  72  kDa  could  be  visualized  after  silver  staining  and  Western  blotting.  Assays
performed  with  ﬂuorescence  resonance  energy  transfer  (FRET)  selective  ACE  substrates  Abz-FRK(Dnp)P-
OH,  Abz-SDK(Dnp)P-OH  and  Abz-LFK(Dnp)-OH,  allowed  us to  verify  that  crab-ACE  has  hydrolytic  proﬁle
very similar  to that of the  ACE  C-domain.  In addition,  we  observed  that  crab-ACE  can  hydrolyze  the
ACE  substrates,  angiotensin  I and  bradykinin.  The  enzyme  was  strongly  inhibited  by  the  speciﬁc  ACEharacterization
RET peptides
inhibitor  lisinopril  (Ki of  1.26  nM).  However,  in  contrast  to other  ACE  isoforms,  crab-ACE  presented  a  very
particular  optimum  pH,  being  the substrate  Abz-FRK(Dnp)-P-OH  hydrolyzed  efﬁciently  at pH  9.5.  Other
interesting  characteristic  of crab-ACE  was  that  the  maximum  hydrolytic  activity  was  reached  at  around
45 ◦C. The  description  of  an  ACE  isoform  in  Ucides  cordatus  is  challenging  and  may  contribute  to  a  better
understanding  of the  biochemical  function  of  this  enzyme  in  invertebrates.
© 2014  Elsevier  B.V.  All  rights  reserved.. Introduction
Angiotensin I-converting enzyme (ACE) is a zinc-dependent
etallopeptidase that hydrolyzes angiotensin I, releasing the
otent vasopressor angiotensin II [1] and inactivates the vasode-
ressor bradykinin [2,3]. In mammals, ACE is associated with renin
s part of the homeostatic mechanism that controls blood pressure
4,5] and electrolyte balance [6]. ACE is found as a somatic iso-
orm (150–180 kDa) that contains two active sites within a single
olypeptide sequence [7,8] and a smaller isoform (90–110 kDa) that
s present exclusively in male germinal cells, apparently performing
eproductive functions [9].
Components of the renin–angiotensin system (RAS) and ana-
ogues of ACE have been identiﬁed in many invertebrate species,
laying roles in reproduction, osmoregulation, memory processes
nd immune system regulation [10]. Isoforms of ACE can be found
∗ Corresponding author at: Departamento de Informática em Saúde, Universidade
ederal de São Paulo, Rua Botucatu, 862, Térreo, São Paulo, SP, Brazil.
E-mail address: bersanetti@unifesp.br (P.A. Bersanetti).
ttp://dx.doi.org/10.1016/j.ijbiomac.2014.12.036
141-8130/© 2014 Elsevier B.V. All rights reserved.in annelids [11,12], crustaceans [13–17], molluscs [18], insects
[19] and prokaryotes [20,21]. However, little is known about
the angiotensin system components in invertebrates, particularly
about the role that ACE plays in this group.
In crustaceans, the enzyme presents high polymorphism and is
found as single or two  domains forms in a variety of tissues [15].
In these invertebrates, ACE seems to regulate the balance of body
ﬂuids during water deprivation [14] and may  be responsible for
the degradation of crustacean hyperglycemic hormone involved in
carbohydrate and osmotic balance [13].
Ucides cordatus is a strong osmotic regulator crab found in
mangrove areas, which shows ﬂuctuation in water salinity that
varies from freshwater to almost full seawater. To survive in these
environments, this crab presents morphological and physiological
differences in their gills [22]. The anterior gills have a thin epithe-
lium to allow gas exchange, performing a respiratory function. On
the other hand, the posterior gills have a thick epithelium that
facilitates ion exchange, presenting ion transporters at the plasma
membrane [23]. As very little is known about ACE in crustaceans,
the objective of this work was  to describe and characterize an ACE
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urther understand the biochemical properties of this enzyme in
nvertebrates.
. Material and Methods
.1. Animals
The crabs (Ucides cordatus) were collected at Itanhaém in São
aulo Coast (Lat. 24◦10′59′′S; Long. 46◦47′20′′W),  and brought to
he laboratory where they were acclimatized for a week. The
rabs were kept in tanks ﬁlled with artiﬁcial sea water at 20 ppt,
ravel, water ﬁlter and pieces of brick for the emersion of the
nimals. Photoperiod (12:12) was constant as well as the tem-
erature (22 ± 3 ◦C). The salinity at 20 ppt was  chosen because at
his condition the animals are at osmotic equilibrium with outside
nvironment.
.2. Preparation of gill homogenate
Gills ﬁlaments of ﬁve crabs were separated in anterior and pos-
erior parts. For the experiments was used only the anterior gills
hat were pooled together, cut with scissors and frozen at −80 ◦C
or posterior use. Gills were homogenized in ice using a homog-
nizer (Ika T-10 basic—Ultra Turrax) in 0.05 M Tris–HCl, pH 8.0,
ontaining 0.01% Triton X-100. The homogenate was centrifuged
wice at 4000 rpm for 15 min, at 4 ◦C, and the supernatant was used
o characterize the ACE.
.3. ACE puriﬁcation by Sepharose-lisinopril afﬁnity
hromatography
ACE from anterior gill homogenate was puriﬁed by Sepharose-
isinopril afﬁnity chromatography, as previously described [24].
he homogenate was desalted in a PD-10 column before the puriﬁ-
ation. The Sepharose-lisinopril column was washed with 0.02 M
EPES containing 0.3 M NaCl, pH 8.0 and the elution was  carried
ut with 0.05 M sodium borate, pH 9.5.
.4. Electrophoresis and Western blotting
The Sepharose-lisinopril puriﬁed fraction was analyzed by SDS-
AGE and Western blotting performed on a 10% polyacrylamide
el. The proteins were stained with silver nitrate or transferred to
 nitrocellulose membrane (BioRad, CA, USA). For Western blot-
ing analysis, the membrane was incubated for 45 min  in 0.020 M
ris–HCl, pH 7.5, containing 0.15 M NaCl, 0.05% Tween-20 and
 mg/mL  bovine serum albumin, prior to overnight incubation with
nti-angiotensin converting enzyme antibody, clone 9B9 (Milli-
ore) diluted 1:500, as determined by Dot Blot protocol.
.5. Synthesis of FRET peptides
The ﬂuorescence resonance energy transfer (FRET) peptide
bz-FRQ-EDDnp, which contains the group EDDnp (N-[2-4-
initophenyl]-ethylenediamine) attached to a glutamine residue,
as synthesized by the solid-phase synthesis method as described
lsewhere [25] using an automated solid-phase peptide synthe-
izer Shimadzu model PSSM-8. The FRET peptides, containing the
np group coupled to the -NH2 of a Lys residue, were synthe-
ized by solid phase methodology as previously described [26].
he peptides were puriﬁed by semi-preparative HPLC, monitored
y absorbance at 220 nm and by ﬂuorescence emission at 420 nm
ollowing excitation at 320 nm.  The molecular mass of puriﬁed pep-
ides was checked by MALDI-TOF mass spectrometry (TofSpec-E,
icromass). All peptides were stocked in DMSO and the concen-
rations measured using the molar extinction coefﬁcient of Dnpogical Macromolecules 74 (2015) 304–309 305
and EDDnp (ε365 = 17,300 M−1 cm−1). Angiotensin I and bradykinin
were purchased from Sigma-Aldrich Corp. (St Louis, MO,  USA).
2.6. Determination of ACE activity in anterior gill homogenate
ACE catalytic activity was  determined in anterior gill
homogenates using the FRET peptides Abz-FRK(Dnp)P-OH, Abz-
SDK(Dnp)P-OH [26], Abz-LFK(Dnp)-OH [27] and Abz-FRQ-EDDnp.
The hydrolysis was  monitored in a Hitachi F-2000 ﬂuorimeter
by continuously measuring the ﬂuorescence (ex = 320 nm and
em = 420 nm)  for 5 min. 10–30 l of the homogenate was incu-
bated with 10 M of the FRET substrates, at 37 ◦C, in 0.1 M Tris–HCl,
pH 7.0, containing 0.050 M NaCl and 10 M ZnCl2, in a ﬁnal volume
of 0.35 ml.  The slope was converted into nanomole of the substrate
hydrolyzed per minute based on a calibration curve obtained by
complete hydrolysis of the peptides. We included in the buffer
inhibitors that we  wanted to suppress the hydrolytic activities
(10 M E64, 1 M pepstatin, 1 mM PMSF). The speciﬁcity of the
assay was  demonstrated adding 10 M lisinopril.
2.7. Determination of pH, NaCl and temperature inﬂuence on
crab-ACE activity
The pH dependence in crab-ACE hydrolysis was  determined
using 10 M of Abz-FRK(Dnp)P-OH as substrate in a pH range of
5.0–10.5. A four-component buffer comprised of 25 mM glycine,
25 mM acetic acid, 25 mM Mes, and 75 mM Tris–HCl [28] was used.
The hydrolysis was  monitored as described above and velocity of
hydrolysis was  determined for each pH value.
To study the inﬂuence of NaCl (0–0.5 M)  on the catalytic activity
of crab-ACE, the enzyme was  incubated with 10 M of Abz-
FRK(Dnp)P-OH, at 37 ◦C, in 0.05 M sodium borate (pH 9.5). The
hydrolysis was monitored as described above and the velocity of
hydrolysis was  determined for each NaCl concentration.
The effect of temperature (20–55 ◦C) on crab-ACE activity was
determined in 0.05 M sodium borate, pH 9.5, using 10 M of Abz-
FRK(Dnp)P-OH as substrate. The enzyme was pre-incubated for
5 min  at different temperatures and the hydrolysis was monitored
continuously at ex = 320 nm and em = 420 nm.  The velocity of
hydrolysis was  determined for each temperature value.
2.8. Determination of crab-ACE activity
The hydrolytic activity of Sepharose-lisinopril puriﬁed fraction
(crab-ACE) upon the FRET peptides was  determined for anterior gill
homogenate. The assays were performed in 0.05 M sodium borate
pH 9.5 at 37 ◦C. The Km and Kcat determination for the hydroly-
sis of Abz-FRK(Dnp)P-OH by crab-ACE was  performed in 0.05 M
borate buffer at pH 9.5. The enzyme concentration for initial rate
was chosen so as to hydrolyze less than 5% of the substrate present.
To correct the inner ﬁlter effect was  used an adjusting equation
determined experimentally for 0.1–100 M of Abz-FR-OH [26]. The
Km was calculated from the kinetic parameters by the non-linear
regression data analysis Graﬁt program [29] and the standard devi-
ations values was less than 7%.
2.9. Inhibitory effect of lisinopril on crab-ACE
The inhibition of crab-ACE by lisinopril (3–55 nM)  was  stud-
ied using Abz-FRK(Dnp)P-OH as substrate. The assays were carried
out in 0.05 M sodium borate (pH 9.5), at 37 ◦C, after 10 min  pre-
incubation of the enzyme with the inhibitor. Fluorescence emission
was continuously measured at ex = 320 nm and em = 420 nm.
Velocities were determined with less than 5% of substrate hydrol-
ysis in the absence and in the presence of different inhibitor
concentrations. The IC50 value was obtained by data analysis in




















































Fig. 2. Determination of the hydrolytic activity in anterior gill homogenate using06 P.A. Bersanetti et al. / International Journal 
raﬁt program [29]. The Ki values for the ACE inhibitor were calcu-
ated by the following equation:
V0
V1
= 1 + [I]
Kiapp
.10. Determination of the cleavage sites
For the determination of the scissile bonds, crab-ACE was incu-
ated for 4 h with the natural ACE substrates angiotensin I and
radykinin and with the FRET peptides Abz-FRK(Dnp)P-OH, Abz-
DK(Dnp)P-OH and Abz-LFK(Dnp)-OH. The assays were performed
n 0.05 M sodium borate, pH 9.5, at 37 ◦C. The products were ana-
yzed by LC/ESI-MS in a Shimadzu apparatus, model 2010 with a
PD-20A Shimadzu UV/vis detector (Tokyo, Japan) and RF-10AXL
uorescence detector (Shimadzu, Tokyo, Japan) coupled with an
ltrasphere C-18 column (5 m,  4.6 × 250 mm).  A linear gradient
f 10–80% of solvent B (0.1% TFA in 3:1 acetonitrile/H2O) for 20 min
as used after 8 min  of isocratic ﬂow of solvent A (0.1% TFA in H2O).
.11. Phylogeny studies
Sequence data were obtained from NCBI (v161) and aligned
sing three distinct methods, CLUSTAL v2.1 [30], MUSCLE v3.8.31
31] and the alignment using HMMER3 [32] to the ACE domain
eptidase M2 (PF01401.13) of Pfam database [33]. The phylogeny
f the aligned sequences data was inferred with PhyML [34], with
he HKY85 substitution model. The multiple alignments of the ACE
omain was used to infer the phylogenic tree.
. Results
.1. Puriﬁcation of ACE by Sepharose-lisinopril afﬁnity
hromatography
The homogenate obtained from the crab anterior gills was
uriﬁed by Sepharose-lisinopril afﬁnity chromatography (960×
uriﬁcation) to apparent homogeneity. Fig. 1 shows the SDS-PAGE
nd the Western blot obtained after the puriﬁcation process. A band
f about 72 kDa was visualized after staining with silver nitrate
Fig. 1A) or revelation with monoclonal anti-ACE antibody 9B9
Fig. 1B)..2. Activity determination
The ACE catalytic activity in the crude crab homogenate
as assayed in 0.1 M Tris–HCl, pH 7.0, containing 0.050 M NaCl
ig. 1. Characterization of crab-ACE puriﬁcation by Sepharose-lisinopril afﬁnity
hromatography. (A) SDS-PAGE (10%) stained with silver nitrate: lane 1, MW stan-
ards (Spectra Multicolor Broad Range Protein Ladder–Thermo Scientiﬁc); lane 2,
nterior gill homogenate; lane 3, puriﬁed crab-ACE. (B) Western blotting analysis
evealed with anti-ACE antibody.FRET substrates. The activity for each peptide was considered 1.0 and relative activ-
ities after inhibition with lisinopril were calculated. See Material and Methods
section for the hydrolysis conditions.
and 10 M ZnCl2, with the substrates Abz-FRK(Dnp)P-OH, Abz-
LFK(Dnp)-OH, Abz-SDK(Dnp)P-OH and Abz-FRQ-EDDnp (Fig. 2).
The anterior crab homogenate could hydrolyze all the tested sub-
strates, however, the activity was not totally inhibited by 10 M
of lisinopril (Fig. 2). This result indicated that, besides ACE, other
proteases present in the anterior gill homogenate are capable
to hydrolase the tested peptides. Corroborating this ﬁnding, we
observed that the FRET peptide Abz-FRQ-EDDnp, with a blocked
C-terminal carboxyl group, was hydrolyzed by a protease differ-
ent from ACE, as the action was not inhibited by the selective ACE
inhibitor lisinopril.
3.3. Inﬂuence of pH and NaCl and temperature in crab-ACE
activity
The effect of pH on the hydrolysis of Abz-FRK(Dnp)-P-OH by
crab-ACE was determined over the pH range of 6.5–10.5 (Fig. 3A).
The higher hydrolytic activity was  observed at pH 9.5. The inﬂuence
of NaCl was also determined using Abz-FRK(Dnp)P-OH as substrate
(Fig. 3B). The enzyme reached maximum activity at 75 mM NaCl,
however no signiﬁcant chloride anion activation was  detected,
even at high salt concentration.
The temperature inﬂuence on the hydrolysis of Abz-FRK(Dnp)P-
OH by crab-ACE was studied over a range of 20–55 ◦C (Fig. 4). The
maximum activity was  reached at around 45 ◦C and after this value,
the catalytic activity declined as a result of enzyme thermal dena-
turation.
3.4. Determination of crab-ACE activity and cleavage sites
Isolated crab-ACE demonstrated a select activity towards ACE
substrates (Fig. 5). The enzyme was able to hydrolyze Abz-
FRK(Dnp)P-OH with a Km value of 5.5 ± 0.5 M and kcat value of
1.9 ± 0.1 min−1 (Fig. 6). The ACE C-domain selective substrate Abz-
LFK(Dnp)-OH was  also cleaved by the crab-ACE with a Km value of
−16.5 ± 0.3 M and kcat value of 0.8 ± 0.05 min (data not shown),
while the ACE N-domain-substrate Abz-SDK(Dnp)P-OH was  resis-
tant to hydrolysis. As expected, the peptide Abz-FRQ-EDDnp with
the carboxyl group blocked was not cleaved by crab-ACE.
P.A. Bersanetti et al. / International Journal of Biological Macromolecules 74 (2015) 304–309 307
Fig. 3. pH dependence (A) and NaCl effect (B) on Abz-FRK(Dnp)P-OH hydrolysis














The renin–angiotensin system in invertebrates has been














The cleavage sites determined for natural ACE substrates and
RET peptides was analyzed by LC/ESI-MS (Table 1). The crab-ACE
as able to hydrolyze Abz-FRK(Dnp)P-OH at the R–K bond and the
-domain-speciﬁc substrate Abz-LFK(Dnp)-OH at the L–F. The nat-
ral ACE substrates angiotensin I (DRVYIHPFHL) was  cleaved by
rab-ACE only at the F–H bond, generating angiotensin II (m/z 1045)
hile bradykinin (RPPGFSPFR) was hydrolyzed at sequential cleav-
ge sites releasing the C-terminal dipeptides F–R and S–P, as seen
ith ACE [2].able 1








Abz-FRQ-EDDnp ResistantFig. 4. Effect of temperature on Abz-FRK(Dnp)P-OH hydrolysis by puriﬁed crab-ACE.
The hydrolysis conditions are described in the Materials and Methods section.
3.5. Effect of lisinopril in crab-ACE activity
Using the substrate Abz-FRK(Dnp)P-OH we determined the
inhibition constant for the ACE inhibitor lisinopril (Fig. 7). The IC50
value determined for crab-ACE was  8.6 ± 0.2 nM and the Ki value
was 1.26 ± 0.04 nM,  indicating that this speciﬁc ACE inhibitor is also
very potent for crab-ACE.
3.6. Phylogenetic inference
The phylogenetic inference results (Fig. 8) obtained based on
the ACE domain region presented a topology, which is consistent
with the genealogy of the taxa. This suggests the orthology of the
sequences used for the gene tree.0
0.2
Fig. 5. Relative activity of the puriﬁed crab-ACE using FRET peptides. Maximum
activity was  considered 1.0 and relative activity values were calculated. See Material
and Methods section for the hydrolysis conditions.
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Fig. 8. Phylogenetic tree inferred for homologous ACE proteins. The ACE sequences
and  accession numbers used for the phylogenetic analysis were: Carcinus
maenas (CAX63316), Pontastacus leptodactylus (CAX48990.1), Locusta migratoria
(AAR85358.1), Drosophila melanogaster (AAF53353.2), Strongylocentrotus purpura-
tus (XP 798092.2), Xenopus tropicalis (AAI59327.1), Homo sapiens (AAA60612.1),
Oryctolagus cuniculus (CAA44428.1), Cynoglossus semilaevis (XP 008312995.1),he hydrolysis was  continuously monitored in a ﬂuorimeter and the data ﬁtted
o Michaelis–Menten kinetics. The details are described in Material and Methods
ection.
smoregulation, reproduction, memory processes and immune
ystem regulation. However, in invertebrates the biologically active
eptides that ACE cleaves still needs to be elucidated. In the present
ork, we described the isolation and characterization of a met-
llopeptidase in anterior gills of the crab Ucides cordatus, which
howed properties similar to mammalian angiotensin I-converting
nzyme (ACE). The puriﬁed peptidase, here denominated crab-
CE, presented carboxydipeptidyl activity and no endopeptidase
ctivity upon the tested substrates. The cleavage pattern pre-
ented for the hydrolysis of the substrates Abz-FRK(Dnp)-P-OH,
bz-LFK(Dnp)-OH, angiotensin I and bradykinin is identical to that
bserved for the mammalian ACE. Another characteristic observed
s that crab-ACE is not capable to hydrolyze peptides with blocked
arboxyl group, as observed for the peptide Abz-FRQ-EDDnp.
The SDS-PAGE and Western blotting analysis showed the
resence of a single domain enzyme in crab-ACE with about
2 KDa. Other characteristic of crab-ACE similar to the mammalian
soform is the Km value determined for the hydrolysis of the Abz-
RK(Dnp)P-OH (5.5 M).  This value is close to the Km value of
Concentration of lisinopril (nM)

















ig. 7. Puriﬁed crab-ACE inhibition by lisinopril. The inhibitory activity was  deter-
ined by measuring the remaining hydrolytic activity after pre-incubation (10 min)
f  active enzyme with different inhibitor concentrations. The enzyme–inhibitor
ixture was  added to a solution containing Abz-FRK(Dnp)P-OH in the same buffer.Alligator mississippiensis (XP 006271633.1), Gallus gallus (ETE62480.1), Hydra vul-
garis (XP 004208490.1), Theromyzon tessulatum (AAS57725), Crassostrea gigas
(EKC26119.1).
4.0 M described for the hydrolysis of the same FRET peptide by
recombinant wild-type ACE [26]. The NaCl effect on crab-ACE activ-
ity was  also very similar to the proﬁle showed by recombinant
wild-type ACE [26] as well as the inhibition by the lisinopril.
Curiously, crab-ACE is different from humans and other mam-
malian isoforms, in the pH proﬁle, with maximum activity at pH 9.5.
This optimum pH suggests that an amino acid residue in catalytic
site must be deprotonated for optimal activity of the crab-ACE.
Corroborating this result, the substrate Abz-SDK(Dnp)P-OH, having
an acid residue in the S1 subsite [35], was not hydrolyzed by the
crab-ACE. An ACE isoform from mollusk Mytilus edulis hydrolyzed
angiotensin I at optimum pH of about 8.4 [36]. In addition, Lipke
et al. showed that an ACE isoform present in ﬁsh is active over
a broad range of pH with an optimum activity on the substrate
hippuryl-l-histidyl-l-leucine (HHL) at pH 10.5 [37]. These authors
suggested that poikilothermic animals have blood pH that varies
with changes in environmental temperature. Therefore, aquatic
organisms that do not maintain constant body temperature, such
as crustaceans, should have enzymes that function well over a wide
pH range, as observed here.
Crab-ACE maximum activity was  achieved at 45 ◦C, decreasing
at higher temperatures. Takada et al. showed that kidney ACE
of different mammalian species is stable at 40 ◦C, with posterior
inactivation [38]. O’Neill et al., using site-directed mutagenesis to
reduce N-glycans contents in C- and N-domain of ACE, demon-
strated a decrease in thermal stability, suggesting that certain
N-glycans have an important effect on the thermodynamic prop-
erties of the enzyme. This authors also demonstrated that the ACE
N-domain is more thermostable than the C-domain, probably due
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rab- ACE thermal stability, we can speculate that the enzyme
resents a low level of glycosylation, which is consistent with the
-domain characteristic.
We found a molecular mass for crab-ACE of around 72 kDa,
uggesting that it is a single domain enzyme. Several ACE iso-
orms present in invertebrates are described as containing only
ne domain. Laurent and Salzet [11] described an ACE isoform
n brain of leech as a single domain enzyme. Other mollusks also
ontain ACE as a single domain [36] in pedal ganglia and in these
rganisms this enzyme is implicated in the metabolism of several
europeptides. Most insects have single domain enzyme [40,41]
xcept for Anopheles,  having an ACE with two domain structure
19]. A two-domain enzyme was also characterized in crustaceans
epatopancreas [15], suggesting that the evolution of this enzyme
s far from complete.
The results obtained from the alignment of the active sites of
CE from different species demonstrated that the representative
rganisms from the Phylum Arthropoda (Carcinus maenas, Pontas-
acus leptodactylus, Locusta migratoria and Drosophila melanogaster)
re phylogenetically close as shown in the phylogenetic tree. As
xpected, the vertebrate cluster of ACE isoforms is distinct from the
rthropod cluster. The presence of ACE with two domains in various
pecies suggests that the gene duplication may  have occurred very
arly in evolution, as a common ancestor of Arthropoda, Cnidaria
nd Chordata appeared 700 million years ago. It is still possible that
he ACE gene duplication occurred more than once in evolutionary
ime frame [42].
. Conclusion
We  puriﬁed and characterized an ACE isoform (crab-ACE) from
nterior gills of Ucides cordatus that presents many properties sim-
lar, but temperature and pH activities were very different from
ammalian ACE. Further studies are necessary to elucidate the nat-
ral substrates and the physiological function of this ACE isoform
n the gills of these invertebrates.
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